Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph not_applicable
4
67%
Ph phase_3
1
17%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
4(80.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Active(3)
Other(3)

Detailed Status

Suspended2
Not yet recruiting2
Enrolling by invitation1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 31 (20.0%)
N/A4 (80.0%)

Trials by Status

suspended233%
not_yet_recruiting233%
enrolling_by_invitation117%
unknown117%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
PROCEDURE
Total Trials
6